ライフサイエンスコーパス: immunoglobulin

1 ample, antiviral agents, corticosteroids, or immunoglobulin.

2 ned: 38 to eltrombopag and 36 to intravenous immunoglobulin.

3 , plasma exchange, and high-dose intravenous immunoglobulin.

4 eltrombopag was non-inferior to intravenous immunoglobulin.

5 of foscarnet, and anti-Cytomegalovirus human immunoglobulin.

6 lonal human (p < 0.0001) or rat (p = 0.0017) immunoglobulins.

7 eleased either unbound (free SC) or bound to immunoglobulins.

8 degrade unusually large amounts of abnormal immunoglobulins.

9 groups: cadherins, integrins, selectins, and immunoglobulins.

10 CDAT score and anti-tissue transglutaminase immunoglobulin A (anti-t-TG-IgA) titer was assessed.

11 ng antibodies, promotes systemic and mucosal immunoglobulin A (IgA) and T cell responses, and almost

12 Norovirus-specific immunoglobulin A (IgA) levels in baseline saliva samples

13 is necessary for the induction of intestinal immunoglobulin A (IgA).

14 Secretory immunoglobulin A (SIgA) is the single most abundant acqu

15 Secretory immunoglobulin A (sIgA) represents the immune system's f

16 y pathway that involves intestinal secretory immunoglobulin A (sIgA).

17 (SARS-CoV-2), including immunoglobulin G and immunoglobulin A antibodies.

18 study of Bangladeshi children, greater fecal immunoglobulin A, but not plasma immunoglobulin G, direc

19 sensitive, and noninvasive determination of immunoglobulins A specific to SARS-CoV-2 (IgA) in saliva

20 (61%) of 36 patients assigned to intravenous immunoglobulin (absolute risk difference 17.8%, one-side

21 Corticosteroid and high-dose intravenous immunoglobulin achieved remission in 50% (n = 18), addit

22 uorinated glucocorticoids and/or intravenous immunoglobulin) after enrollment but prior to a primary

23 Specific immunoglobulin against protein antigen was immobilized o

24 g filament and exhibits a complex pattern of immunoglobulin and fibronectin domains.

25 tors - including members of the human T cell immunoglobulin and mucin domain (TIM)-family - have gain

26 e investigate the checkpoint molecule T cell immunoglobulin and mucin domain-containing 3 (Tim-3), wh

27 T cell immunoglobulin and mucin domain-containing protein 3 (TI

28 Along with other immune checkpoints, T cell immunoglobulin and mucin domain-containing protein 3 (Ti

29 , programmed cell death 1 (PD-1), and T cell immunoglobulin and mucin domain-containing protein 3 (TI

30 Intravenous immunoglobulin and plasmapheresis (PLEX) have limited su

31 IgE is the least abundant immunoglobulin and tightly regulated, and IgE-producing

32 Serum immunoglobulins and complement factors, peripheral blood

33 une response comprising enzymes, complement, immunoglobulins and crucially, a range of anti-viral and

34 dary outcomes were changes in grass specific immunoglobulins and skin and nasal provocation tests to

35 ies antibodies was used to determine chicken immunoglobulins and, accordingly, chicken meat in food p

36 tion proteins, reduced brain infiltration of immunoglobulin, and attenuated neuroinflammation.

37 microproteinuria concentrations of albumin, immunoglobulin, and hemoglobin, giving a prediction erro

38 Epidermal Growth Factor, Fibronectin Type 3, Immunoglobulin, and Thrombospondin type 1 domains, which

39 The roles of the plasma-like B cell produced immunoglobulins, and their interacting proteins in the p

40 Candidate IRRSs IMORAB2, from human rabies immunoglobulin; and GCIRAB1, from pooled serum samples f

41 blood, and plasma levels of peanut-specific immunoglobulins, are useful biomarkers for peanut OIT.

42 ch-format lateral flow immunoassay (LFIA) of immunoglobulins as a biomarker for species identificatio

43 human serum and saliva, and for quantifying immunoglobulin avidities against coronavirus antigens fr

44 basophil responsiveness and peanut-specific immunoglobulins between those who were clinically reacti

45 alpha-helix and beta-sheet site of GB1, the immunoglobulin binding domain of protein G.

46 The endoplasmic reticulum (ER) immunoglobulin binding proteins (BiPs) are molecular cha

47 target recognition, including members of the immunoglobulin, cadherin, and leucine-rich repeat superf

48 uced basophil activation and peanut-specific immunoglobulins can help to predict treatment outcomes,

49 le, diversity, and joining recombination and immunoglobulin class switch recombination, here, using C

50 asure different classes of immunoglobulin or immunoglobulin combinations and detect antibodies direct

51 ACE2 collectrin domain and fusion to a human immunoglobulin crystallizable fragment (Fc) domain for i

52 Monobodies are synthetic non-immunoglobulin customizable protein binders invaluable t

53 ation, nonsteroid immunosuppressive therapy, immunoglobulin deficiency, asplenia, and/or other rare c

54 were offered MMR vaccination or intravenous immunoglobulin depending on their transplant phase and r

55 ed a specific and sensitive immunosensor for immunoglobulin detection produced against SARS-CoV-2.

56 dependent unfolding and refolding of a titin immunoglobulin domain and alpha-actinin spectrin repeats

57 ditions indicates that the unfolding of each immunoglobulin domain can be explained by a simple two-s

58 hat cell adhesion molecule transmembrane and immunoglobulin domain containing 1 (TMIGD1) are highly e

59 expressed on activated T lymphocytes, V-type immunoglobulin domain-containing suppressor of T cell ac

60 in conjunction with mechanical loading, that immunoglobulin domains preferentially from the distal ti

61 llergens by skin prick and allergen-specific immunoglobulin E (IgE) (ImmunoCAP((R))) tests.

62 About 20 years after the identification of immunoglobulin E (IgE) and its key role in allergic hype

63 Exposure to allergens crosslinks immunoglobulin E (IgE) antibodies that are bound to mast

64 ing the serum of the patient showed specific immunoglobulin E (IgE) positivity for wasps; therefore,

65 abilities, we analyzed a published model for immunoglobulin E (IgE) receptor signaling using syntheti

66 Targeting of immunoglobulin E (IgE) represents an interesting approac

67 Assessing immunoglobulin E (IgE) sensitization to allergens is an

68 lpha), IL-6, IL-12/23, IL-17, IL-4/13, IL-5, immunoglobulin E (IgE), integrins and B cells.

69 orm of treatment for patients suffering from immunoglobulin E (IgE)-associated allergy; the most comm

70 parvalbumin, which was shown to have reduced immunoglobulin E (IgE)-binding capacity upon calcium dep

71 Immunoglobulin E (IgE)-mediated anaphylaxis is a potenti

72 Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled all

73 llergic reactions that are often mediated by immunoglobulin E (IgE).

74 bited increased blood levels of Ova-specific immunoglobulin E (IgE).

75 tors, including interleukin-5 (IL-5), IL-13, immunoglobulin E and eosinophils.

76 f macrophages that express the high-affinity immunoglobulin E receptor FcepsilonRIalpha and are in cl

77 DEIA groups, except for level of total serum immunoglobulin E.

78 Immunoglobulins E (IgEs) trigger allergic reactions by s

79 sdAbs are small, compact, thermostable immunoglobulin elements capable of binding targets with

80 Immunoglobulin eluted from the glomeruli of HCMVpp65(422

81 test system can reliably recognize specific immunoglobulins even after heat processing.

82 Global proteomics identified the immunoglobulin family of cell adhesion molecules (IgCAMs

83 colitis models in response to interleukin-22 immunoglobulin Fc (IL22Fc) fusion protein and anti-p40 m

84 enter who received orally administered human immunoglobulin for norovirus enteritis, and it appeared

85 g is an effective alternative to intravenous immunoglobulin for perioperative treatment of immune thr

86 errucosa 1-specific immunoglobulin isotypes; immunoglobulin free light chains; cytokines; and chemoki

87 ic immunoglobulin receptor (pIgR) transports immunoglobulins from the basolateral to the apical surfa

88 blood eosinophils seeded on heat-aggregated immunoglobulin G (HA-IgG).

89 ow immunoassay test that detected SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibo

90 om bradyzoite infection by identification of immunoglobulin G (IgG) antibodies against T. gondii embr

91 Immunoglobulin G (IgG) antibodies against the capsular p

92 mmunofluorescence antibody assay to identify immunoglobulin G (IgG) antibodies reactive with Ricketts

93 successful induction of J8-specific systemic immunoglobulin G (IgG) antibodies when administered subc

94 Mumps virus-specific immunoglobulin G (IgG) antibody responses and mumps viru

95 f PCV and were assessed for antipneumococcal immunoglobulin G (IgG) antibody titers against the 7 ser

96 Immunoglobulin G (IgG) antibody was not required for Fcg

97 e 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against

98 However, immunoglobulin G (IgG) can also stimulate antiviral resp

99 They were predominantly of the immunoglobulin G (IgG) class and targeted the S2 subunit

100 ollapsin response-mediator protein 5 (CRMP5) immunoglobulin G (IgG) has been associated with paraneop

101 ted by detecting different concentrations of Immunoglobulin G (IgG) in both phosphate buffered saline

102 Calves with lower concentrations of immunoglobulin G (IgG) in their blood, have a greater ri

103 ad a combined diagnostic efficacy similar to immunoglobulin G (IgG) index and neurofilament light cha

104 (FcgammaRs) translate antigen recognition by immunoglobulin G (IgG) into various immune responses.

105 Myd88 repression leads to a decrease in immunoglobulin G (IgG) production against AAV2/1 and AAV

106 tion by naive B cells, which promoted B cell immunoglobulin G (IgG) production.

107 The anti-CIP immunoglobulin G (IgG) was deposited on a silica optical

108 tigen-coated beads to quantify the levels of immunoglobulin G (IgG), IgM and IgA antibodies against f

109 rus, herpes simplex virus, and HCMV-specific immunoglobulin G (IgG), serum markers of inflammation, a

110 n this study, we developed novel recombinant immunoglobulin G (IgG)-binding luciferase-based signal a

111 omboembolism complicates disorders caused by immunoglobulin G (IgG)-containing immune complexes (ICs)

112 ia and prolonged COVID-19 symptoms, negative immunoglobulin G (IgG)-IgM SARS-CoV-2 serology, and posi

113 ses is blocked by autologous contemporaneous immunoglobulin G (IgG).

114 ]) to investigate the persistence of measles immunoglobulin G (IgG).

115 dard markers of glomerular proteinuria (e.g. immunoglobulin G [IgG]), urinary nephrin excretion (podo

116 determined the prevalence of anti-SARS-CoV-2 immunoglobulin G among blood donors in Kenya in April-Ju

117 ndrome coronavirus 2 (SARS-CoV-2), including immunoglobulin G and immunoglobulin A antibodies.

118 on and 1 week postvaccination was tested for immunoglobulin G antibodies to P. falciparum circumsporo

119 itive in 33.6%, whereas immunoglobulin M and immunoglobulin G antibodies were positive in 15.7% cases

120 complementarity determining regions of human Immunoglobulin G antibodies with target affinities that

121 latelets, which is their unique receptor for immunoglobulin G antibodies, positions them to ideally r

122 by measuring serotype-specific pneumococcal immunoglobulin G antibody concentrations at baseline and

123 mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral sp

124 etitive Luminex immunoassay (cLIA) and total immunoglobulin G assay.

125 Immunoglobulin G developed rapidly and was sustained at

126 Therefore, immunoglobulin G from 18 acute iTTP patients was purifie

127 94 anti-SARS-CoV-2 antibodies and found that immunoglobulin G heavy-chain variable region 3-53 (IGHV3

128 antibodies were positive in 15.7% cases and immunoglobulin G in 43.6% cases, respectively, when chec

129 -neutralizing antibodies and anti-RSV fusion immunoglobulin G increased >=4-fold in 95% and 100% of v

130 -19) and expressed anti-spike protein trimer immunoglobulin G inhibited angiotensin-converting enzyme

131 MG involved an immunoglobulin G isotype in all patients, with a predomi

132 Nab titers and immunoglobulin G levels were correlated in donor plasma

133 ition was correlated with anti-spike protein immunoglobulin G levels, neutralizing titers in a pseudo

134 he anti-L-type voltage-gated calcium channel immunoglobulin G purified from patients with idiopathic

135 out jointly to find significant differential immunoglobulin G responses.

136 Among patients with residual disease, the immunoglobulin G signature was an independent, good prog

137 eptide microarray was designed to screen for immunoglobulin G targeting epitopes from all known cardi

138 Antitetanus immunoglobulin G titers were similar between groups.

139 vant showed a rapid increase in anti-EBOV GP immunoglobulin G titers with peak titers observed on Day

140 vidin to biotinylated spheres and binding of immunoglobulin G to spheres functionalized with protein

141 ined continuum model of the antibody protein immunoglobulin G using fluctuating finite element analys

142 Here, three model proteins, immunoglobulin G, alpha-chymotrypsinogen A, and lysozyme

143 e also studied the presence of EBOV-specific immunoglobulin G, antinuclear antibodies, anti-cyclic ci

144 No differences in EBOV-specific immunoglobulin G, antinuclear antibody, or anti-cyclic c

145 the sandwich immunoassay developed for mouse immunoglobulin G, detection limits of 1.5 ng/mL and >10

146 eater fecal immunoglobulin A, but not plasma immunoglobulin G, directed against the Cryptosporidium s

147 radish peroxidase, chicken avidin, and human immunoglobulin G, respectively.

148 PT and anti-FHA (P < .001), but not anti-PRN immunoglobulin G, were observed among 69 wP-vaccinated i

149 also enrich glycans from ovalbumin and human immunoglobulin G.

150 in/blood ratio >300-fold higher than that of immunoglobulin G/liposomes.

151 um is needed to complement tests that detect immunoglobulins G and M.

152 onally describe the longitudinal dynamics of immunoglobulin-G (IgG), immunoglobulin-M (IgM), and in v

153 possible to detect single binding events of immunoglobulin-G-coated polystyrene beads, which are hel

154 ed animals given a wild-type (WT) anti-HIV-1 immunoglobulin G1 (IgG1) versus those given a Fc-Null va

155 Serum anti-GD2 (immunoglobulin G1 [IgG1] and IgM) and anti-GD3 (IgG1) ti

156 ing of a VWF-D'D3 domain fused to rFVIII via immunoglobulin-G1 Fc domains and 2 XTEN polypeptides (Am

157 in (MS) II, showed consistent enhancement of immunoglobulin G2a (IgG2a) production when it was in for

158 prepared libraries from T-cell receptor and immunoglobulin gene rearrangements in context of lymphop

159 om HIV-1-infected individuals are encoded by immunoglobulin gene rearrangments with infrequent naive

160 V antibodies are encoded by a diverse set of immunoglobulin genes and recognize various conformationa

161 rainbow' cell-fate mapping and sequencing of immunoglobulin genes from single cells, we find that 5-1

162 The characteristics of their immunoglobulin genes offer insights into the underlying

163 s adverse events occurred in the intravenous immunoglobulin group (atrial fibrillation, pancreatitis,

164 Here, we characterized polyclonal immunoglobulin Gs (IgGs) and Fabs from COVID-19 convales

165 High-dose IV immunoglobulin (HDIVig), alone or in combination with st

166 ifferent effector functions, B cells undergo Immunoglobulin Heavy Chain (IgH) class switch recombinat

167 ch depends on contraction of the 2.8-Mb-long immunoglobulin heavy chain (Igh) locus by Pax5(17,18).

168 ancer-binding protein homologous protein and immunoglobulin heavy chain binding protein UPR-response

169 recursor B cells (PreB cells) is dictated by immunoglobulin heavy chain checkpoint (IgHCC), where the

170 he HLA-DQA1 to HLA-DQB1 region, but also the immunoglobulin heavy chain locus, including the IGHV4-61

171 Locus B of immunoglobulin heavy chain mapped to an area containing

172 esenting increased PC differentiation and no immunoglobulin heavy chain production.

173 mice) that often have canonical CDR3s in the immunoglobulin heavy chain that, owing to junctional bia

174 Using deep sequencing, we analyzed the immunoglobulin heavy chain variable region repertoire in

175 se, which expressed a Pax5 minigene from the immunoglobulin heavy-chain locus.

176 omavimab) or the reference arm, Human rabies immunoglobulin (HRIG; Imogam(R) Rabies-HT), in a ratio o

177 Secretory (S) Immunoglobulin (Ig) A is the predominant mucosal antibod

178 n-induced cytidine deaminase (AID) initiates immunoglobulin (Ig) class switch recombination (CSR), so

179 d by costimulation blockade using the CTLA-4-immunoglobulin (Ig) fusion protein (abatacept) in a mous

180 A therapeutic immunoglobulin (Ig) G(1) monoclonal antibody lost more t

181 Immunoglobulin (Ig) gene rearrangements and oncogenic tr

182 Immunoglobulin (Ig) glycosylation is recognized for its

183 ains unclear, but the role of the monoclonal immunoglobulin (Ig) light chain (LC) is strongly suspect

184 As malignant B cells will express either immunoglobulin (Ig) light chain kappa or lambda, we desi

185 tivation-induced cytidine deaminase (AID) to immunoglobulin (Ig) loci promotes antibody class switch

186 th and Human Services from 2008 to 2017 with immunoglobulin (Ig) M and IgG tested at diagnosis were c

187 ed with glycoprotein-specific T-cell but not immunoglobulin (Ig) M or IgG antibody responses.

188 within the first 5 days after disease onset, immunoglobulin (Ig) M, IgA, and total antibody ELISAs in

189 , hepatitis B core antibody (anti-HBc) total immunoglobulin (Ig) or IgG, and antibody to hepatitis B

190 V-domain immunoglobulin (Ig) suppressor of T cell activation (VIS

191 We discovered that SAMHD1 localizes at the immunoglobulin (Ig) switch region, and serves as a novel

192 A panel of cytokines and anti-toxin A and B immunoglobulin (Ig) were measured in serum; calprotectin

193 of cytotoxic T lymphocyte antigen 4 (CTLA-4) immunoglobulin (Ig), Qa-1 mutant mice developed robust d

194 imiting vaccine responsiveness, we developed immunoglobulin (Ig)-knockin mice with elevated numbers o

195 In addition to immunoglobulin (Ig)G and IgM serology and traditional re

196 50) and a 161-fold increase in GI.1-specific immunoglobulin (Ig)G titers when compared with baseline.

197 ement of Mycoplasma pneumoniae (Mp)-specific immunoglobulin (Ig)M antibody-secreting cells (ASCs) imp

198 ARS-CoV-2 infection, we show seroconversion (immunoglobulin (Ig)M, IgA, IgG) in >95% of cases and neu

199 ed individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, an

200 However, immunoglobulin (IgG)-based rabies postexposure prophylax

201 igh pressure thermal (HPT) processing on the immunoglobulin (IgM, IgA and IgG), and cytokine content

202 ell activation, structures, and functions of immunoglobulins; interactions between microbes and immun

203 of bleeding during surgery, and intravenous immunoglobulin is commonly used to increase the platelet

204 was also evaluated for detection of multiple immunoglobulin isotypes, with successful detection of Ig

205 genetic manipulation in PCs in vivo, across immunoglobulin isotypes.

206 asal, total, and Betula verrucosa 1-specific immunoglobulin isotypes; immunoglobulin free light chain

207 d pre- and postadministration of intravenous immunoglobulin (IVIG) from patients with group A Strepto

208 ed trial to evaluate efficacy of intravenous immunoglobulin (IVIG) in reducing seizure frequency.

209 Intravenous immunoglobulin (IVIg) is widely used for severe infectio

210 e report the effect of high-dose intravenous immunoglobulin (IVIg) on safety, tolerability, pharmacok

211 ndomized controlled trial of CMV intravenous immunoglobulin (IVIG) prophylaxis.

212 Although intravenous immunoglobulin (IVIG) treatment reduces the risk of deve

213 In Alzheimer's disease, intravenous immunoglobulin (IVIg), a fractionated human blood produc

214 isease that showed resistance to intravenous immunoglobulin (IVIG).

215 ds, dupilumab, interferon-gamma, intravenous immunoglobulins (IVIG), mepolizumab, methotrexate (MTX),

216 e tissue-including plasma cells that express immunoglobulin J-which also accrue concurrently across d

217 and recombination signal-binding protein for immunoglobulin kappa J region (RBPJkappa).

218 of a pathogenic human LC gene into the mouse immunoglobulin kappa locus, ensuring its production by a

219 We identified significant differences in immunoglobulin kappa-chain V-II levels in KC patients co

220 e (Env) vaccines to rhesus macaques and bnAb immunoglobulin knock-in (KI) mice expressing diverse pre

221 ritubular amorphous deposits of a monoclonal immunoglobulin LC, leading to nodular glomerulosclerosis

222 lute numbers of lymphocyte subsets and serum immunoglobulin levels were all within normal ranges.

223 Overall, 25% of patients with immunoglobulin light chain (AL) amyloidosis die within 6

224 ed from the same clone with 100% paired IGH: immunoglobulin light chain (IGK) sequences.

225 sis (AL), fibrillar deposition of monoclonal immunoglobulin light chains (LCs) in vital organs, such

226 min consists of four extracellular bacterial immunoglobulin-like (Big) domains, D00-D2, extending int

227 p combines with part of the C-Lip to form an immunoglobulin-like domain and the remaining C-Lip forms

228 and complementation, in which the incomplete immunoglobulin-like fold of each FimA subunit is complem

229 Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is expressed on ma

230 etin-1, angiopoietin-2, tyrosine kinase with immunoglobulin-like loop epidermal growth factor homolog

231 these HLA-B57 allomorphs by the killer cell immunoglobulin-like receptor (KIR) 3DL1 was compared.

232 uman leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) regions.

233 the inhibitory receptor leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1).

234 e functions and are modulated by killer cell immunoglobulin-like receptors (KIR).

235 cell reactivity mediated through killer cell immunoglobulin-like receptors (KIRs) could reduce the ri

236 ligands for inhibitory and activating killer immunoglobulin-like receptors (KIRs) which are found on

237 pressed mainly by NK cells and for leukocyte immunoglobulin-like receptors (LILRs) on myeloid cells.

238 ZP proteins have an immunoglobulin-like three-dimensional structure and a ZP

239 The immunoglobulin-like ZPN and ZPC subdomains of each monom

240 ed diseases have been treated by nonspecific immunoglobulin-lowering/modulating therapies, including

241 und in the brain and form part of the IgLON (Immunoglobulin LSAMP, OBCAM, Neurotrimin) family.

242 MBC) response was mediated by both classical immunoglobulin M (IgM) (IgM(+)CD27(+)) and switched immu

243 tected SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies was undertaken under m

244 lso displayed low Ki-67, CD49d, cell-surface immunoglobulin M (IgM) expression and IgM-signaling resp

245 (sCD14) and endotoxin core antibody (EndoCAb immunoglobulin M [IgM]) in plasma.

246 coronavirus 2 was positive in 33.6%, whereas immunoglobulin M and immunoglobulin G antibodies were po

247 termined that the measurement of Mp-specific immunoglobulin M antibody-secreting cells (ASCs) by enzy

248 At best response, median serum immunoglobulin M declined from 3,520 to 821 mg/dL, bone

249 The antibody assay detected immunoglobulin M in 87% (52 of 60) COVID-19-positive ser

250 IRI induces immunoglobulin M-dependent complement activation on endo

251 6 or more days after symptom onset (and the immunoglobulins M and G in all 33 samples collected at l

252 itudinal dynamics of immunoglobulin-G (IgG), immunoglobulin-M (IgM), and in vitro neutralizing antibo

253 o and suggest that the hypothesis that human immunoglobulins may affect C. neoformans virulence in vi

254 soluble (s) CD25 (sCD25) and soluble T-cell immunoglobulin mucin domain-3 (sTIM-3) (markers of T-cel

255 This arose from a reduction in T cell immunoglobulin mucin receptor-4 (TIM-4), a phosphatidyls

256 of these patients also received intravenous immunoglobulin; one made a full recovery, 10 of 12 made

257 f technologies, measure different classes of immunoglobulin or immunoglobulin combinations and detect

258 Steroids, intravenous immunoglobulin, or plasma exchange were used in 100 (86%

259 t (alternative pathway and component 5), and immunoglobulins, particularly IgG, were critical for act

260 s, as their health depends on treatment with immunoglobulin preparations that need to contain neutral

261 Testing 54 intravenous immunoglobulin preparations, produced from plasma collec

262 d protection against invading pathogens, via immunoglobulin production and other memory functions.

263 all B-cell clone, responsible for monoclonal immunoglobulin production.

264 fects observed with the blood derived rabies immunoglobulin products has led to search for alternativ

265 The accumulation of the immunoglobulin protein beta(2)-microglobulin (beta(2)m)

266 d mass spectrometry method termed monoclonal immunoglobulin rapid accurate mass measurement (miRAMM)

267 Immunoglobulin reactivity in supernatants of stimulated

268 The polymeric immunoglobulin receptor (pIgR) transports immunoglobulin

269 As the unique source of diverse immunoglobulin repertoires, B lymphocytes are an indispe

270 All survivors were off immunoglobulin replacement and had protective vaccine re

271 Current treatment includes immunoglobulin replacement and immunosuppressive agents.

272 Regular immunoglobulin replacement treatment reduced the inciden

273 r patients with XLA, revealing that although immunoglobulin replacement treatment reduces the inciden

274 lymphocyte count and remained on intravenous immunoglobulin replacement, 2 had second HCT, and 3 died

275 g via RARalpha impacts the allergen-specific immunoglobulin response directly by the differentiation

276 which includes the administration of Rabies immunoglobulin (RIG).

277 severely impaired proliferation and in vitro immunoglobulin secretion.

278 Single-cell immunoglobulin sequencing (scIg-Seq) was performed on a

279 tients, of whom 915 (87.4%) were aquaporin-4 immunoglobulin seropositive.

280 Intravenous immunoglobulin, steroids, and other immunomodulatory age

281 ace and secreted proteins, most of which are immunoglobulin superfamily (IgSF) proteins, using a high

282 Despite its clinical relevance, the immunoglobulin superfamily (IgSF) remains uncharacterize

283 Two conserved IgCAMs (immunoglobulin superfamily cell adhesion molecules), neu

284 d increased expression of T-cell stimulating immunoglobulin superfamily members CD300LB, CD83, SIGLEC

285 ding neurexins, neuroligins, protocadherins, immunoglobulin superfamily proteins, and leucine-rich re

286 flammatory transmembrane glycoprotein in the immunoglobulin superfamily.

287 lobulin M (IgM) (IgM(+)CD27(+)) and switched immunoglobulin (swIg(+)) MBC populations; however, class

288 ying whether inactivation of the cytoplasmic immunoglobulin tail tyrosine (ITT) motif in transmembran

289 All patients recovered after intravenous immunoglobulin therapy.

290 Neutralizing antibodies rose in tandem with immunoglobulin titers following symptom onset, and posit

291 R4(late) biopsies showed immunoglobulin transcripts and injury-related transcript

292 Sialic acid-binding immunoglobulin-type lectins (Siglecs) are expressed on t

293 ngineered mice that have a full set of human immunoglobulin variable region genes.

294 22.3), del(17)(p13.1), complex karyotype, or immunoglobulin variable region heavy chain mutation stat

295 Treatment with IV immunoglobulins was associated with improved survival (o

296 Fresh frozen plasma and immunoglobulins were administered after each session to

297 Patients are often treated with intravenous immunoglobulin which is both expensive and ineffective i

298 characterized by the production of unfolded immunoglobulins, which cause endoplasmic reticulum (ER)

299 All patients received intravenous immunoglobulin, with adjunctive steroid therapy used in

300 Previous intravenous immunoglobulin within 2 weeks or thrombopoietin receptor